Micafungin Versus Amphotericin B Lipid Complex for the Prevention of Invasive Fungal Infections in High-Risk Liver Transplant Recipients

Antifungal Management Practices in Liver Transplant Recipients

(2010) N. Singh et al.   AMERICAN JOURNAL OF TRANSPLANTATION

A retrospective analysis of the use of caspofungin in recipients of liver transplant with a modified high index of suspicion for fungal infection. A critical review of mortality, acute cellular rejection, infections, and changes in the liver function test

(2010) Cataldo Doria et al.   CLINICAL TRANSPLANTATION

Clinical Practice Guidelines for the Management of Candidiasis: 2009 Update by the Infectious Diseases Society of America

(2009) Peter G. Pappas et al.   CLINICAL INFECTIOUS DISEASES

Antifungal prophylaxis in liver transplant recipients

(2009) Gregory A. Eschenauer et al.   LIVER TRANSPLANTATION

Prophylaxis With Caspofungin for Invasive Fungal Infections in High-Risk Liver Transplant Recipients

(2009) Jesus Fortún et al.   TRANSPLANTATION

Valganciclovir as preemptive therapy for cytomegalovirus in cytomegalovirus-seronegative liver transplant recipients of cytomegalovirus-seropositive donor allografts

(2008) Nina Singh et al.   LIVER TRANSPLANTATION

Protothecosis after liver transplantation

(2008) Masashi Narita et al.   LIVER TRANSPLANTATION

Renal impairment and Amphotericin B formulations in patients with invasive fungal infections

(2008) Faouzi Saliba et al.   MEDICAL MYCOLOGY